Clinical trials are prospective biomedical or behavioural research studies involving human subjects that aim to provide answers to particular questions about biomedical or behavioural interventions. These include both established and novel treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) as well as interventions that have already been tried and tested but still require more research and comparison. Data on dosage, safety, and effectiveness are produced by clinical trials. In the nation where therapy approval is sought, they are only carried out after receiving approval from the health authority or ethics committee. These authorities are in charge of evaluating the trial's risk/benefit ratio; their approval merely permits the trial to proceed and does not imply that the therapy is "safe" or effective. In small pilot studies, researchers first enrol volunteers or patients, depending on the product type and stage of development.
Title : Spillover at the edge: Mapping zoonotic disease risk in the wildland-urban interface
Roman Sharnuud, University of Tennessee, United States
Title : AI for good? Expanding our understanding of opinion leaders in a changing digital landscape
Amelia Burke Garcia, NORC at the University of Chicago, United States
Title : Confidence as care: Empowering under represented voices in public health leadership and community engagement
Sheena Yap Chan, The Tao of Self-Confidence, Canada
Title : Redefining eHealth literacy for the digital age: A scoping review to advance equity, engagement, and behaviour change
Comfort Sanuade, Concordia University, Canada
Title : Innovative approaches in public health leadership: Empowering communities for resilient health systems
Mohammad Kamal Hussain, Umm Al-Qura University, Saudi Arabia
Title : Assessing human exposure to key chemical carcinogens diagnostic approaches and interpretation
Vladan Radosavljevic, Military Medical Academy, Serbia